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Abstract 
We audited whether
 18
F-Fuorodeoxyglucose positron emission tomography-computed 
tomography (
18
FDG PET-CT) imaging could discriminate between different diagnoses in HIV-
infected patients presenting with lymphadenopathy, with or without fever and/or 
splenomegaly. Maximum standardised uptake (SUVmax) values were similar in lymphoma 
and mycobacterial and fungal infections, and were lower but similar in those with HHV 8-
associated disease and HIV-associated reactive lymphadenopathy. Nodal 
18
FDG avidity, with 
SUVmax ≥10, excluded diagnoses of HHV 8-associated disease and miscellaneous conditions, 
and HIV-associated reactive lymphadenopathy was additionally excluded in those who had 
undetectable plasma viral loads. This audit suggests 
18
FDG PET-CT imaging did not permit 
discrimination between specific diagnoses, but has utility in identifying lymph nodes with 
increased avidity that could be targeted for biopsy and in ruling out significant pathology.  
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Introduction 
The immunosuppressed HIV-infected patient can present with lymphadenopathy, with or 
without a fever and/or splenomegaly [1]. The differential diagnosis for this presentation is 
wide, and includes Hodgkin and non-Hodgkin lymphoma, human herpesvirus 8 (HHV 8)-
associated disease, including Kaposi sarcoma (KS) and multicentric Castleman disease 
(MCD), Mycobacterium tuberculosis, disseminated Mycobacterium avium complex, 
leishmaniasis and histoplasmosis [1–3], as well as other conditions such as metastatic 
carcinoma and HIV-associated “reactive” lymphadenopathy.  Definitive diagnosis often 
requires tissue sampling with histology and/or microbiological culture in addition to 
traditional investigations. 
18
F-fluorodeoxyglucose positron emission tomography-computed 
tomography (
18
FDG PET-CT) hybrid imaging, already widely used in the diagnosis, staging 
and monitoring of malignancies, particularly lymphoma, is increasingly used to image 
infectious and inflammatory disorders in both immune-competent and immune-suppressed 
individuals [1, 4–11]. We audited whether 
18
FDG PET-CT could aid in discriminating between 
diagnoses in HIV-infected patients presenting with lymphadenopathy, with or without fever 
and/or splenomegaly. 
  
Methods 
Consecutive patients who presented with lymphadenopathy, with or without fever and/or 
splenomegaly, at the HIV service at Mortimer Market Centre (MMC) and University College 
Hospitals (UCLH) London between January 2008 and December 2016 and who underwent 
18
FDG PET-CT scanning as part of routine clinical investigation were identified from the UCLH 
Clinical Data Repository (CDR) system. Information collected from the CDR and the patient’s 
clinical case notes included their presenting symptoms and signs, the maximum 
standardised uptake value (SUVmax) in node(s) or other tissue on 
18
FDG PET-CT imaging, CD4 
count, plasma HIV load, and whether the patient was receiving antiretroviral therapy (ART) 
at the time of diagnosis. The diagnosis of lymphoma, HHV 8-associated disease and HIV-
associated reactive lymphadenopathy was made histologically, while that of mycobacterial 
and fungal infections was made by microbiological culture, as previously described [12]. In 
each patient 
18
FDG PET-CT scanning was done prior to tissue sampling, and before results of 
microbiological culture were available. Patients in whom a tissue diagnosis of malignancy 
had been made and who subsequently underwent 
18
FDG PET-CT scanning for staging were 
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excluded, as were those with undifferentiated fever, or pyrexia of undetermined origin 
(PUO). Results were analysed using Mann-Whitney and Kruskal-Wallis tests to compare 
SUVmax values among different patient groups. GraphPad Prism Version 6.0h (GraphPad 
software, Inc, La Jolla, CA, USA) was used for statistical analysis; p<0.05 was regarded as 
statistically significant.  
 
Results 
One hundred and twenty patients (88 men) presented with lymphadenopathy, with or 
without fever and/or splenomegaly, and underwent 
18
FDG PET-CT. Figure 1 shows the 
clinical features at presentation. Patients were aged 42 years (33–48) [median (interquartile 
range: IQR)]. Forty-five patients were receiving ART and had an undetectable plasma HIV 
load (<50 copies/ml) [median (IQR) CD4 =400 (200–520) cells/µl], while 17 others were 
receiving ART but had detectable viral loads [median (IQR) =1700 (110–2850) copies/ml, 
CD4 =200 (155–340) cells/µl]. Fifty-eight patients were not receiving ART and had 
detectable viral loads [median (IQR) HIV plasma load =155,000 (15,250–550,000) copies/ml, 
and median (IQR) CD4 =185 (80–360) cells/µl].  
 
The final diagnosis was HIV-related reactive lymphadenopathy in 43 patients, lymphoma in 
27 (Hodgkin lymphoma in 13, diffuse large B-cell in 7, Burkitt in 3, plasmablastic in 3 and T-
cell in 1), HHV 8-associated disease in 19 (KS in 5, MCD in 7 and KS with MCD in 7), 
mycobacterial infection in 14 (M. tuberculosis in 8, M. avium complex in 6), and fungal 
infections in 4 (Cryptococcus neoformans in 3, histoplasmosis in 1). Thirteen patients had a 
wide range of miscellaneous conditions: these were adult-onset Still’s disease, sclerosing 
peritonitis, intra-abdominal sepsis, metastatic adenocarcinoma, reflux oesophagitis/benign 
colonic polyp, lobar pneumonia, visceral leishmaniasis, necrotizing granulomatosis, nodular 
hepatic fibrosis secondary to schistosomiasis, toxoplasmosis, and nodular hepatic 
fibrosis/portal hypertension with thyrotoxicosis/thyroiditis, each in one patient, and self-
limiting febrile episodes with lymphadenopathy in two patients. 
.  
SUVmax values were similar in lymphoma and mycobacterial and fungal infections and were 
lower but similar in those with HHV 8-associated disease and HIV-associated reactive 
lymphadenopathy. Individuals with miscellaneous (largely non-infectious and non-malignant 
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conditions) had low SUVmax values (Table 1). Across all diagnoses, there were statistically 
significant differences in median SUVmax when lymphoma was compared with HIV reactive 
lymphadenopathy (p=0.0007) and with HHV 8-associated diseases (p=0.0008), and when 
mycobacterial infection was compared with HIV reactive and HHV 8-associated diseases 
(p=0.004 and p<0.0001, respectively). No statistically significant differences were found 
between the other groups of diagnoses. Within each diagnostic group, median SUVmax 
showed no significant differences in those with detectable and those with undetectable viral 
loads (Table 1). Among all patients, nodal FDG avidity, with SUVmax ≥10, excluded diagnoses 
of HHV 8-associated disease and miscellaneous conditions, and HIV-associated reactive 
lymphadenopathy was additionally excluded in those in receipt of ART who had 
undetectable plasma viral loads. Reversal of the liver:spleen 
18
FDG avidity ratio was 
observed more commonly among those with detectable viral loads but did not aid 
discrimination between diagnoses.  
 
Discussion 
This audit shows similar avidity of 
18
FDG uptake, measured by SUVmax, in patients with 
lymphoma, mycobacterial infection and fungal infection; accordingly, 
18
FDG-PET-CT imaging 
did not provide diagnostic information enabling discrimination between these diagnoses. A 
SUVmax ≥10 enabled HHV 8-associated disease and miscellaneous conditions to be excluded 
in all patients, and additionally, in those in receipt of ART who had undetectable plasma 
viral loads HIV-associated reactive lymphadenopathy could be excluded. This observation 
requires validation in prospective studies before it is used in diagnostic algorithms. In HIV 
infected patients different pathology may occur concurrently. This audit did not identify any 
features on 18FDG PET-CT imaging that suggested coexistence of dual or multiple 
pathology. The utility of 
18
FDG PET-CT imaging was in identifying lymph nodes with 
increased avidity that could be targeted for biopsy and in excluding significant pathology. 
The limitations of this audit are first, it is from a single centre, and second, the sample size is 
small. Additionally, patients with undifferentiated PUO, and those with an established tissue 
diagnosis of malignancy prior to 18FDG PET-CT scanning were excluded.  
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Table 1. Median SUVmax and diagnosis in 120 patients who underwent 
18
FDG PET-CT imaging 
Diagnosis (n) SUVmax median (IQR) 
HIV-related reactive lymphadenopathy (43) 
  Undetectable viral load (9) 
  Detectable viral load (34) 
5.6 (3.3–9.4) 
3.7 (3.0–6.3) 
6.0 (3.3–9.7) 
Lymphoma (27) 
  Undetectable viral load (17) 
  Detectable viral load (10)  
12.0 (6.5–14.0) 
12.5 (6.8–18.1) 
12.0 (5.5–13.3) 
HHV 8-associated disease (KS/MCD) (19) 
  Undetectable viral load (5) 
  Detectable viral load (14) 
5.7 (4.5–7.5) 
5.7 (3.5–7.1) 
5.9 (4.3–8.9) 
Mycobacterial infection (14) 
  Undetectable viral load (2) 
  Detectable viral load (12) 
10.9 (9.1–13.9) 
8.7  
12.3 (9.2–14.6) 
Fungal infection (4) 
  Undetectable viral load (3) 
  Detectable viral load (1) 
13.3 (6.4–20.6) 
13.5 (4.2–23.0) 
13.2 
Miscellaneous conditions* (13) 
  Undetectable viral load (9) 
  Detectable viral load (4) 
2.0 (2.0–6.1) 
2.0 (2.0–7.1) 
2.0 (2.0–2.5) 
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Figure 1. Clinical features at presentation among 120 HIV-infected patients who underwent 
(
8
FDG PET-CT imaging 
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